Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
Clinical trial NCT00284531 · TERMINATED
Trial details
- NCT number
- NCT00284531
- Sponsor
- Baylor College of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2007-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.